Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 382

1.

C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.

Elstein D, Nir A, Klutstein M, Rudensky B, Zimran A.

Blood Cells Mol Dis. 2005 May-Jun;34(3):201-5.

PMID:
15885602
2.

N-brain natriuretic peptide: correlation with tricuspid insufficiency in Gaucher disease.

Elstein D, Nir A, Klutstein M, Abrahamov A, Zimran A.

Pulm Pharmacol Ther. 2004;17(5):319-23.

PMID:
15477128
3.

Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.

Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.

Coron Artery Dis. 2009 May;20(3):219-24. doi: 10.1097/MCA.0b013e3283219e47.

PMID:
19322079
4.

N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.

Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemöller K, von Beckerath N, von Beckerath O, Vogt W, Schömig A.

Am J Med. 2006 Apr;119(4):355.e1-8.

PMID:
16564781
5.

Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.

Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H, Pachinger O, Mair J.

Heart. 2009 Feb;95(4):297-303. doi: 10.1136/hrt.2008.145425. Epub 2008 Aug 15.

PMID:
18708421
7.

Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.

Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.

Circulation. 2005 Jul 5;112(1):110-6. Epub 2005 Jun 27.

8.

N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.

J Hypertens. 2006 Aug;24(8):1531-9.

PMID:
16877955
9.

Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.

Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C.

Cytokine. 2009 Sep;47(3):166-72. doi: 10.1016/j.cyto.2009.06.003. Epub 2009 Jul 14.

PMID:
19604708
10.

Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room.

Möckel M, Müller R, Vollert JO, Müller C, Carl A, Peetz D, Post F, Kohse JK, Lackner KJ.

Clin Chem. 2005 Sep;51(9):1624-31.

12.

Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.

Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H.

Clin Endocrinol (Oxf). 2005 Nov;63(5):493-8.

PMID:
16268799
13.

Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.

Weber M, Hausen M, Arnold R, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C.

Int J Cardiol. 2008 Jul 21;127(3):321-7. Epub 2007 Dec 11.

PMID:
18055041
14.

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

Toblli JE, Lombraña A, Duarte P, Di Gennaro F.

J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65.

15.

High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.

Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.

Arthritis Rheum. 2008 Jan;58(1):284-91. doi: 10.1002/art.23187.

16.

N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.

Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS.

Int J Cardiol. 2008 Jun 6;126(3):322-32. Epub 2007 Jun 4.

PMID:
17544525
17.
18.

Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.

Voskaridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E.

Haematologica. 2007 Jun;92(6):738-43.

19.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

20.

N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.

Hong SN, Yoon NS, Ahn Y, Lim SY, Kim YS, Yun KH, Kang DK, Lee SH, Lee YS, Kim KH, Son IS, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Circ J. 2005 Dec;69(12):1472-6.

Items per page

Supplemental Content

Write to the Help Desk